Biomimetic inventions face the same challenge as any other innovation in bringing a product or process from concept to market.
Swedish Biomimetics 3000® is addressing this opportunity by operating under its innovation accelerating model, V²IO®.
Read more about Swedish
Biomimetics 3000 ›
September 2015 Drug Making Breaks Away From Its Old Ways
Continuous-Manufacturing’ Process Can Improve Quality Control, Speed Output. Wall Street Journal, By Jonathan D Rockoff Read the article ›
SWEDEN CORPORATE OFFICE SWEDISH
Ingmar Bergmans gata 2, 5tr
114 34 Stockholm, Sweden See all our offices ›